Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides

Abstract Recent advances in the clinical development of oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs, have attracted attention as promising therapeutic modalities for genetic and intractable diseases. These oligonucleotide therapeutics exert thei...

Full description

Saved in:
Bibliographic Details
Main Authors: Kohshi Kusumoto, Kiyomi Sasaki, Yasunori Uchida, Ayaka Utsumi, Tokuyuki Yoshida, Satoshi Obika, Takao Inoue, Keiichiro Okuhira
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84310-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559686161104896
author Kohshi Kusumoto
Kiyomi Sasaki
Yasunori Uchida
Ayaka Utsumi
Tokuyuki Yoshida
Satoshi Obika
Takao Inoue
Keiichiro Okuhira
author_facet Kohshi Kusumoto
Kiyomi Sasaki
Yasunori Uchida
Ayaka Utsumi
Tokuyuki Yoshida
Satoshi Obika
Takao Inoue
Keiichiro Okuhira
author_sort Kohshi Kusumoto
collection DOAJ
description Abstract Recent advances in the clinical development of oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs, have attracted attention as promising therapeutic modalities for genetic and intractable diseases. These oligonucleotide therapeutics exert their efficacy by binding to target RNAs present within cells; however, the mechanisms underlying their cellular uptake, especially their passage through membranes, remain largely unclear. In the nematode, Caenorhabditis elegans, the multi-pass transmembrane protein, SID-1, is involved in the cellular uptake of double-stranded RNAs. In mammals, SIDT1 and SIDT2 (SID-1 transmembrane family, members 1 and 2, respectively) are homologs of SID-1, yet their functional differences are not fully understood. In this study, we conducted a comparative analysis of the amino acid sequences of mammalian SIDT1 and SIDT2 to identify regions characteristic to each. By inducing SIDT1 or SIDT2 expression in human cell lines, we demonstrated that SIDT2 enhanced the knockdown activity of gapmer ASOs and potentially promoted their endosomal escape into the cytosol. Furthermore, by analyzing chimeric proteins of SIDT2 and SIDT1, we identified a region in SIDT2 that might be crucial for the enhancement of gapmer ASO activity. These findings elucidate the novel role of SIDT2 in the transport mechanism of gapmer ASOs and are expected to contribute to further development of oligonucleotide therapeutics.
format Article
id doaj-art-bc572341c23147aa888ae31dce15121f
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-bc572341c23147aa888ae31dce15121f2025-01-05T12:18:42ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-024-84310-6Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotidesKohshi Kusumoto0Kiyomi Sasaki1Yasunori Uchida2Ayaka Utsumi3Tokuyuki Yoshida4Satoshi Obika5Takao Inoue6Keiichiro Okuhira7Osaka Medical and Pharmaceutical UniversityDivision of Molecular Target and Gene Therapy Products, National Institute of Health SciencesDivision of Molecular Target and Gene Therapy Products, National Institute of Health SciencesInstitute of Biomedical Sciences, Tokushima UniversityDivision of Molecular Target and Gene Therapy Products, National Institute of Health SciencesGraduate School of Pharmaceutical Sciences, Osaka UniversityDivision of Molecular Target and Gene Therapy Products, National Institute of Health SciencesOsaka Medical and Pharmaceutical UniversityAbstract Recent advances in the clinical development of oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs, have attracted attention as promising therapeutic modalities for genetic and intractable diseases. These oligonucleotide therapeutics exert their efficacy by binding to target RNAs present within cells; however, the mechanisms underlying their cellular uptake, especially their passage through membranes, remain largely unclear. In the nematode, Caenorhabditis elegans, the multi-pass transmembrane protein, SID-1, is involved in the cellular uptake of double-stranded RNAs. In mammals, SIDT1 and SIDT2 (SID-1 transmembrane family, members 1 and 2, respectively) are homologs of SID-1, yet their functional differences are not fully understood. In this study, we conducted a comparative analysis of the amino acid sequences of mammalian SIDT1 and SIDT2 to identify regions characteristic to each. By inducing SIDT1 or SIDT2 expression in human cell lines, we demonstrated that SIDT2 enhanced the knockdown activity of gapmer ASOs and potentially promoted their endosomal escape into the cytosol. Furthermore, by analyzing chimeric proteins of SIDT2 and SIDT1, we identified a region in SIDT2 that might be crucial for the enhancement of gapmer ASO activity. These findings elucidate the novel role of SIDT2 in the transport mechanism of gapmer ASOs and are expected to contribute to further development of oligonucleotide therapeutics.https://doi.org/10.1038/s41598-024-84310-6Antisense oligonucleotideGapmerEndosomal escapeOligonucleotide therapeuticsSIDT1SIDT2
spellingShingle Kohshi Kusumoto
Kiyomi Sasaki
Yasunori Uchida
Ayaka Utsumi
Tokuyuki Yoshida
Satoshi Obika
Takao Inoue
Keiichiro Okuhira
Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
Scientific Reports
Antisense oligonucleotide
Gapmer
Endosomal escape
Oligonucleotide therapeutics
SIDT1
SIDT2
title Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
title_full Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
title_fullStr Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
title_full_unstemmed Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
title_short Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
title_sort multispanning membrane protein sidt2 increases knockdown activity of gapmer antisense oligonucleotides
topic Antisense oligonucleotide
Gapmer
Endosomal escape
Oligonucleotide therapeutics
SIDT1
SIDT2
url https://doi.org/10.1038/s41598-024-84310-6
work_keys_str_mv AT kohshikusumoto multispanningmembraneproteinsidt2increasesknockdownactivityofgapmerantisenseoligonucleotides
AT kiyomisasaki multispanningmembraneproteinsidt2increasesknockdownactivityofgapmerantisenseoligonucleotides
AT yasunoriuchida multispanningmembraneproteinsidt2increasesknockdownactivityofgapmerantisenseoligonucleotides
AT ayakautsumi multispanningmembraneproteinsidt2increasesknockdownactivityofgapmerantisenseoligonucleotides
AT tokuyukiyoshida multispanningmembraneproteinsidt2increasesknockdownactivityofgapmerantisenseoligonucleotides
AT satoshiobika multispanningmembraneproteinsidt2increasesknockdownactivityofgapmerantisenseoligonucleotides
AT takaoinoue multispanningmembraneproteinsidt2increasesknockdownactivityofgapmerantisenseoligonucleotides
AT keiichirookuhira multispanningmembraneproteinsidt2increasesknockdownactivityofgapmerantisenseoligonucleotides